Healthcare - Biotechnology - NASDAQ - US
$ 1.22
-3.17 %
$ 104 M
Market Cap
-0.71
P/E
BALANCE SHEET
361 M
ASSETS
176 M
LIABILITIES
185 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Century Therapeutics, Inc.
| Current Assets | 177 M |
| Cash & Short-Term Investments | 173 M |
| Receivables | 0 |
| Other Current Assets | 4.26 M |
| Non-Current Assets | 184 M |
| Long-Term Investments | 89.1 M |
| PP&E | 92.1 M |
| Other Non-Current Assets | 2.52 M |
| Current Liabilities | 17.8 M |
| Accounts Payable | 2.74 M |
| Short-Term Debt | 1.51 M |
| Other Current Liabilities | 13.6 M |
| Non-Current Liabilities | 158 M |
| Long-Term Debt | 46.7 M |
| Other Non-Current Liabilities | 111 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 47.3 | 84.3 | 56.4 | 27.2 | 44.1 |
| Short Term Investments | 125.4 | 231.2 | 166.4 | 48.5 | 37.5 |
| Receivables | 0 | 0.8 | 0.2 | 0 | 0 |
| Inventory | 0 | 0 | (0.2) | 1.9 | 2.3 |
| Other Current Assets | 4.3 | 3.4 | 5.0 | 3.0 | 2.6 |
| Total Current Assets | 177.0 | 319.7 | 228.2 | 78.8 | 84.1 |
| PP&E | 92.1 | 111.7 | 69.8 | 15.4 | 2.5 |
| Intangible Assets | 0 | 0 | 0 | 9.4 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 89.1 | 51.9 | 135.9 | 1.1 | 4.1 |
| Other Long Term Assets | 2.5 | 3.2 | 3.5 | 1.2 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 360.7 | 486.5 | 437.4 | 106.8 | 90.9 |
| LIABILITIES | |||||
| Accounts Payable | 2.7 | 5.5 | 7.6 | 8.1 | 1.5 |
| Short Term Debt | 1.5 | 7.0 | 1.7 | 0.2 | 0 |
| Other Current Liabilities | 9.2 | 10.2 | 6.4 | 3.8 | 1.4 |
| Total Current Liabilities | 17.8 | 29.8 | 15.7 | 12.1 | 3.0 |
| Long Term Debt | 46.7 | 42.4 | 23.5 | 21.3 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 56 K | 0.7 | 2.0 | 179.8 | 0 |
| Total Liabilities | 175.9 | 183.8 | 41.1 | 213.2 | 182.8 |
| EQUITY | |||||
| Common Stock | 6 K | 6 K | 5 K | 1 K | 1 K |
| Retained Earnings | (655.8) | (519.1) | (388.2) | (292.3) | (238.8) |
| Other Accumulative Comprehensive Income/Loss | 0.1 | (2.5) | (0.7) | 3 K | 3 K |
| Total Equity | 184.8 | 302.7 | 396.2 | (106.4) | (91.9) |
| Total Liabilities and Equity | 360.7 | 486.5 | 437.4 | 106.8 | 90.9 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 59.3 | 57.8 | 55.0 | 54.8 | 54.8 |